spacer
home > pmps > autumn 2003 > direct contact
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Direct Contact

This year's CPhI Worldwide and ICSE will take place from 27th to 29th October 2003 at Messe in Frankfurt. A magnificent metropolis, Frankfurt offers attendees of CPhI and ICSE plenty of opportunity to combine business with pleasure! But more importantly, the expected record-breaking volume of attendees conducting business on a face-to-face basis will ensure that the 14th edition of CPhI is a huge success.


As always you can be sure of a high quality audience when attending CPhI and ICSE; last year's event in Paris attracted 10,096 decision makers from more than a 110 countries. As pharmaceutical CEOs are regular visitors and the event is a haven for attracting new business opportunities, in just three days you can have a world of new products, partnerships and contacts at your fingertips. The event prides itself on offering unrivalled opportunities in the pharma and chemical markets.

So what can you expect in Frankfurt from 27th to 29th October?



Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Joanne Glover at PMPS
spacer
Joanne Glover
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement